Toward the end of trading Tuesday, the Dow traded up 0.92 percent to 16,973.38 while the NASDAQ jumped 1.55 percent to 4,555.50. The S&P also rose, gaining 1 percent to 1,981.17.
Leading and Lagging Sectors
Energy shares rose by 1.89 percent in today’s trading. Top gainers in the sector included Harvest Natural Resources (NYSE: HNR), up 22.3 percent, and Clean Energy Fuels (NASDAQ: CLNE), up 12.4 percent.
Top 5 Cheapest Companies To Own In Right Now: Ishares Xinhua China 25 (FXI)
iShares FTSE/Xinhua China 25 Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the FTSE/Xinhua China 25 Index (the Index). The Index is designed to represent the performance of the largest companies in the China equity market that are available to international investors. The Index consists of Class H and Red Chip shares of 25 of the largest and most liquid Chinese companies. Securities in the Index are weighted based on the total market value of their shares. Each security in the Index is a constituent of the FTSE All-World Index. All of the securities in the Index trade on the Hong Kong Stock Exchange.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Belinda Cao]
The iShares FTSE China 25 Index Fund (FXI), the largest Chinese exchange-traded fund in the U.S., added 0.9 percent May 3 to $37.71, extending its weekly advance to 2.1 percent. The Standard & Poor�� 500 Index climbed 1.1 percent to 1,614.42, bringing its five-day rally to 2 percent.
- [By Jonathan Yates]
China recently announced a series of economic reforms that are very market driven. The main exchange traded fund for China,�iShares China Large-Cap�(NYSE: FXI), is up more than 10 percent for the last month of market action.
- [By Jonathan Yates]
Like a roller coaster, the exchange traded funds for the United States Dollar (NYSE: UUP) and gold, SPDR Gold Shares (NYSE: GLD), have gone up and down in response to statements from the Federal Reserve. What is obvious by the continuation of Quantitative Easing III by Federal Reserve Chairman is that the United States economy is still weak. With that and the improving Chinese economy (NYSE: FXI), the future for gold assets such as the GLD, Barrick Gold (NYSE: ABX), and Wishbone Gold PLC (PINK: WISHY) is bullish.
Top 5 Clean Energy Stocks To Buy For 2014: Chimerix Inc (CMRX)
Chimerix, Inc., incorporated on April, 07, 2000, is a biopharmaceutical company committed to the discovery, development and commercialization of novel, oral antiviral therapeutics that are designed to transform patient care in areas of high unmet medical need. Its lipid technology has given rise to two clinical-stage compounds, CMX001 and CMX157, which have demonstrated the potential for enhanced antiviral activity and safety in convenient, orally administered dosing regimens.
CMX001 is an orally administered drug that utilizes its lipid technology to deliver intracellular concentrations of a potent antiviral compound, cidofovir-diphosphate (CDV-PP). Following oral dosing, CMX001 is absorbed through the gut, remains intact in the plasma, and is readily taken up by and delivered into cells. Once inside cells, CMX001 is converted into CDV-PP, which acts as an alternative substrate in a replicating virus. CMX001 is similar to the drug cidofovir in that both drugs are converted into CDV-PP once inside cells. Although cidofovir is approved for administration in an intravenous formulation, Vistide, it requires a plasma concentration to deliver a therapeutic level of cidofovir into cells and its use is limited due to the risk of kidney damage.
CMX157, Its second clinical stage compound, is an oral nucleotide compound in Phase 1 development for the treatment of human immunodeficiency virus (HIV) infection. In July 2012, the Company granted Merck an exclusive worldwide license to develop and commercialize CMX157 for all human uses. Merck is responsible for all development and marketing activities for CMX157 on a worldwide basis.
Advisors' Opinion:- [By Ben Levisohn]
Biotech companies that are most likely to benefit because they are “Ahead in clinical development and/or have established relationships with [the Biomedical Advanced Research and Development Authority, or] BARDA which may facilitate getting a contract” include GlaxoSmithKline (GSK), NewLink Genetics (NLNK), Johnson & Johnson (JNJ) and Chimerix (CMRX). Kantor includes Tekmira�(TKMR) and Sarepta (SRPT) among “companies with viable programs” that are “moving forward and likely to attract additional funding.”
Top 5 Clean Energy Stocks To Buy For 2014: QUALCOMM Incorporated(QCOM)
QUALCOMM Incorporated engages in the development, design, manufacture, and marketing of digital wireless telecommunications products and services. The company operates in four segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), Qualcomm Wireless and Internet (QWI), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies code division multiple access (CDMA)-based integrated circuits and system software for wireless voice and data communications, multimedia functions and global positioning system products. The QTL segment grants licenses to use portions of its intellectual property portfolio comprising patent rights useful in the manufacture and sale of wireless products, such as products implementing cdmaOne, CDMA2000, WCDMA, CDMA TDD, GSM/GPRS/EDGE, and/or OFDMA standards and their derivatives The QWI segment consists of Qualcomm Internet Services that provides content enablement services for the wireless industry and pu sh-to-talk and other products and services for wireless network operators; Qualcomm Government Technologies, which offers development, hardware, and analytical services to the United States government agencies involving wireless communications technologies; Qualcomm Enterprise Services that provides satellite and terrestrial-based two-way data messaging, position reporting, wireless application services, and managed data services to transportation and logistics companies and other enterprise companies; and Firethorn, which builds and manages software applications that enable mobile commerce services. The QSI segment makes strategic investments to support the worldwide adoption of CDMA- and OFDMA-based technologies and services. QUALCOMM Incorporated primarily operates in China, South Korea, Taiwan, Japan, and the United States. The company was founded in 1985 and is based in San Diego, California.
Advisors' Opinion:- [By Evan Niu, CFA]
A long and winding road
This search is why I'd previously invested in ARM Holdings (NASDAQ: ARMH ) , only to sell (prematurely in hindsight) due to concerns about monetization. I had doubts that ARM's role in the value chain was as envious as I initially thought, and subsequently redeployed my investing dollars into Qualcomm (NASDAQ: QCOM ) , an ARM licensee with a stranglehold on licensing, cellular basebands, and mobile applications processors (three for the price of one!). Qualcomm also has deep ties with Samsung, giving it exposure to the top smartphone makers in the world. No regrets there so far. - [By Dan Caplinger]
But another part of the equation could have come from Qualcomm (NASDAQ: QCOM ) , which announced an RF-module for LTE mobile devices that includes an integrated power amplifier. That poses a big threat to competitors Skyworks Solutions (NASDAQ: SWKS ) and RF Micro Devices (NASDAQ: RFMD ) as well as Avago, because if Qualcomm is able to integrate components that Skyworks, RF, and Avago currently sell separately, then it could lead to a huge loss in revenue for all three component-makers.
- [By Vinay Singh]
When someone expects a lot from you, it might either put a lot of pressure on your performance or even your best might not please them. This is actually what is happening with Qualcomm (QCOM) because despite stellar top and bottom line growth at nearly 24% year-on-year in the last five years, the stock has appreciated just 15%. But Qualcomm still looks good for the long run.
- [By Nick Taborek]
Homebuilders fell 1.9 percent as a group, with PulteGroup Inc. and D.R. Horton Inc. dropping more than 2 percent. Qualcomm Inc. (QCOM) retreated 0.8 percent as Piper Jaffray Cos. cut its rating on the company. Tyson Foods Inc. rose 4.1 percent after reporting third-quarter results that beat estimates.
Top 5 Clean Energy Stocks To Buy For 2014: Molina Healthcare Inc (MOH)
Molina Healthcare, Inc., incorporated on July 24, 2002, provides medicaid-related solutions. The Company operates in two segments: Health Plans and Molina Medicaid Solutions. The Company's Health Plans segment consists of health plans in California, Florida, Michigan, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin, and includes the Company's direct delivery business. The Company's Molina Medicaid Solutions segment provides design, development, implementation, and business process outsourcing solutions to state governments for their Medicaid Management Information Systems (MMIS).As of December 31, 2012, Health Plans segment served approximately 1.8 million members eligible for Medicaid, Medicare, and other government-sponsored health care programs for low-income families and individuals. In June 2013, Molina Healthcare Inc announced that, through its wholly owned subsidiary, Molina Center LLC, it has successfully completed a sale and lease back transaction with the dedicated net lease group of Angelo, Gordon & Co (AG).
The health plans are operated by the Company's wholly owned subsidiaries in those states, each of which is licensed as a health maintenance organization (HMO). The Company's direct delivery business consists of 24 primary care clinics in California, Florida, New Mexico, and Washington, and the Company manages three county-owned primary care clinics under a contract with Fairfax County, Virginia. The Company's Health Plans segment derives its revenue principally in the form of premiums received under Medicaid contracts with the states in which the Company's health plans operate. All of the Company's health plans operate on a single managed care platform for claims processing (the QNXT 4.8 system). MMIS is a core tool used to support the administration of state Medicaid and other health care entitlement programs. Molina Medicaid Solutions holds MMIS contracts with the states of Idaho, Louisiana, Maine, New Jersey, and West Virginia, as well as a contract to provide d! rug rebate administration services for the Florida Medicaid program. The Company arranges health care services for its members through contracts with providers that include independent physicians and groups, hospitals, ancillary providers, and its own clinics. The Company's network of providers includes primary care physicians, specialists and hospitals. The Company contracts with both primary care physicians and specialists many of whom are organized into medical groups or independent practice associations (IPAs).
The Company develops specialized disease management programs that address the particular health care needs of its members. motherhood matters! sm is a comprehensive program designed to improve pregnancy outcomes and enhance member satisfaction. breathe with ease! is a multi-disciplinary disease management program that provides health education resources and case management services to assist physicians caring for asthmatic members between the ages of three and 15. Healthy Living with Diabetes is a diabetes disease management program. Heart Health Living is a cardiovascular disease management program for members who have suffered from congestive heart failure, angina, heart attack, or high blood pressure. The Company provides its members with information to guide them through various episodes of care. This information, which is available in several languages, is designed to educate parents on the use of primary care physicians, emergency rooms, and nurse call centers. The Company's pharmacy management programs focus on physician education regarding appropriate medication utilization and encouraging the use of generic medications. The Company's pharmacists and medical directors work with the Company's pharmacy benefits manager to maintain a formulary that promotes both improved patient care and generic drug use. The Company provides certain centralized medical and administrative services to its health plans pursuant to administrative services agreements, including medical affairs a! nd qualit! y management, health education, credentialing, management, financial, legal, information systems, and human resources services.
The Company competes with HP Enterprise Services, ACS, Computer Services Corporation, and CNSI.
Advisors' Opinion:- [By Susan J. Aluise]
Although big insurers may retreat in the near term, here are three healthcare stocks still poised to win big from the Affordable Care Act:
Healthcare Stocks: Molina Healthcare (MOH)Molina Healthcare (MOH) is an insurance payor focused on the Medicaid niche — it covers an estimates 2 million patients in 11 states.
- [By Daniel Jennings]
The White House was planning a massive Obamacare marketing effort with the help of unions and nonprofit groups. That effort has apparently been put on the backburner.
The Obamacare news didn't help UnitedHealth Group (NYSE: UNH). Its share price fell by .017 percent in mid-day trading on Wednesday. Yet it seemed to help WellPoint (NYSE: WLP). The operator of the Anthem Blue Cross/Blue Shield plans saw its share price rise by .01% on Wednesday . A smaller operator of healthcare plans, Molina Healthcare (NYSE: MOH) saw its share price fall. - [By Seth Jayson]
Molina Healthcare (NYSE: MOH ) reported earnings on April 25. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Molina Healthcare met expectations on revenues and crushed expectations on earnings per share.
No comments:
Post a Comment